MO01.17 Real-World Characteristics and Outcomes of Advanced NSCLC Patients with Exon 19 or 21 EGFR Mutations

Autor: Winfree, K., Molife, C., Peterson, P., Chen, Y., Visseren, C., Beyrer, J., Leusch, M., Dimou, A.
Zdroj: In Journal of Thoracic Oncology January 2021 16(1) Supplement:S23-S23
Databáze: ScienceDirect